J&J Recalls, Stops Selling 3 Versions Of K-Y Jelly
By LINDA A. JOHNSON
Johnson & Johnson has quietly recalled some of its popular personal lubricants in order to avert potentially expensive new regulatory reviews.
In the latest in a string of J&J recalls, the health products giant's McNeil unit removed three types of K-Y Jelly from pharmacy and grocery store shelves, and recalled packages from wholesalers, at the end of January. The recalled brands are K-Y Tingling Jelly, K-Y Sensitive Jelly and K-Y Silk-E Vaginal Moisturizer and Personal Lubricant.
McNeil said Friday that all three are safe and there are no "product performance issues," so consumers can keep using any they have left.But McNeil doesn't plan to return them to the market after the company determined that each might require a detailed review by regulators. McNeil had considered them similar enough to existing products to not require such a review. That's because the lubricants are considered medical devices, rather than medicines. Devices that are equivalent to one already on the market can be sold without a detailed review by the U.S. Food and Drug Administration. "As part of ongoing and detailed internal reviews we decided that these products may require submission of new data and application for a new medical device" approval, McNeil spokeswoman Samantha Lucas wrote in an email response to questions. "Because we decided against submitting new paperwork, we recalled the small amount of product that was still in the market." "This was a business-driven decision," she added. About a dozen types of K-Y Jelly are still available. One other version previously was recalled, but McNeil is working on bringing that one back. Last July, J&J took its K-Y Liquibeads vaginal lubricant off the market, recalling about 69,000 packages of the product. The company said then that the FDA had decided Liquibeads, which the agency had approved as an extension of K-Y Intrigue lubricant, actually needed to go through the full approval process.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV